Since CEACAM1 plays a crucial role in insulin resistance and in NAFLD development, we can hypothesize that pharmacologically upregulating CEACAM1 could be a promising therapeutic approach for the treatment of NAFLD in T1D. The gene discussed is CEACAM1; the disease is type 1 diabetes mellitus.